This article investigated urinary function in elderly vs younger men following robot-assisted radical prostatectomy (RARP) for aggressive prostate cancer (PC). 

The authors concluded that regardless of age, there was an improvement in urinary function after the surgery. 

This study is being conducted in Florida (United States) and New South Wales (Australia) and will investigate the efficacy (effectiveness) and safety of accelerated hypofractionation radiotherapy compared to extended hypofractionation radiotherapy. The success of the study will be based on accelerated hypofractionation radiotherapy being as good as extended hypofractionation radiotherapy. 

This study aimed to investigate the outcomes of intermediate risk-risk prostate cancer after different treatments. This study concluded that prostate surgery might have a higher survival than radiotherapy.

This study aims to test the effectiveness of focal ablation (laser therapy used to remove and kill cancer cells) of large prostate cancer sites using ultrasound and biopsy (tissue samples taken from the cancer site) one year after treatment. The main outcome to be measured will be the removal of cancer cells confirmed by a negative biopsy test, with little damage done to healthy cells around it. This trial is currently recruiting in New York and Texas. 

This study aimed to examine the effectiveness and safety of enzalutamide (Xtandi) in metastatic prostate cancer. This study found that enzalutamide was associated with longer progression-free and overall survival compared to standard of care.

The aim of this trial is to determine the effect of the hormone therapy apalutamide (ARN-509) with or without abiraterone acetate (Zytiga), GnRH agonists or prednisone and whether they improve prostate surgery outcomes in men with high-risk prostate cancer. The outcomes to be measured include erectile function, continence, and effect on tumor size and recurrence.

This study aimed to investigate depression in prostate cancer patients. This study found that depression is a major challenge for prostate cancer survivors.

This study investigated the rate of bladder cancer (BC) and rectal cancer (RC) after localized prostate cancer (PC) treatment.

They found that brachytherapy (BT) increased the risk of BC and RC in these patients. 

This article investigated the safety and efficacy of end-to-side nerve grafting surgery (NGS) in patients with erectile dysfunction (ED) after prostate surgery. 

The authors concluded that NGS was a safe and effective treatment option for these patients.

This study aimed to investigate the use of the 'mini-sling' surgery during placement of penile prosthesis for the treatment of urinary incontinence and climacturia (urine leaking during sexual intercourse) in men with erectile dysfunction after prostate cancer treatment. This study found that this procedure is promising for these patients.